香港聯合交易所有限公司
(香港交易及結算所有限公司全資附屬公司)
THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)

ANNOUNCEMENT

In relation to the matter of
Mingyuan Medicare Development Company Limited
(Incorporated in Bermuda with limited liability)
(Stock Code: 233)

Cancellation of listing

 
The Exchange announces that the listing of the Company's shares will be cancelled with effect from 9:00 am on 23 January 2020 under Rule 6.01A.

Trading in the Company’s shares has been suspended since 1 April 2015. Under Rule 6.01A, the Exchange may delist the Company if trading does not resume by 31 July 2019.

On 23 October 2017, the Securities and Futures Commission (the SFC) exercised its power under section 8(1) of the Securities and Futures (Stock Market Listing) Rules to direct the Exchange to suspend dealings in the shares of the Company.

On 14 July 2015 and 11 April 2019, the Exchange imposed resumption conditions on the Company.

The Company failed to resume trading in its shares by 31 July 2019. On 16 August 2019, the Listing Committee decided to cancel the listing of the Company’s shares on the Exchange under Rule 6.01A.

On 27 August 2019, the Company sought a review of the delisting decision by the GEM Listing Review Committee. On 10 January 2020, the Listing Review Committee upheld the Listing Committee’s decision to cancel the listing of the Company’s shares on the Exchange.  Accordingly, the Exchange will cancel the Company’s listing with effect from 9:00 am on 23 January 2020.

The Exchange has requested the Company to publish an announcement on the cancellation of its listing.

The Exchange advises shareholders of the Company who have any queries about the implications of the delisting to obtain appropriate professional advice.

Ends